Mobile

A Study to Evaluate the Safety and Efficacy of RO7123520 as Adjunct Treatment in Patients With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to TNF-α Inhibitors

Mise à jour : Il y a 4 ans
Référence : EUCTR2016-002126-36

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

•To assess the safety, tolerability and efficacy of RO7123520 as adjunctive treatment with Methotrexate (MTX) and anti- Tumor necrosis factor-α (TNF-α) therapy in patients with moderately to severely active RA with an anti-TNF-α inadequate response (Study Parts 1,2, 3)

Critère d'inclusion

  • Rheumatoid Arthritis

Liens